AZN.d Icon

$AZN.d

$AZN.d

AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States...

Stocks
Non-U.S. Global Retail

Total Asset Value

$2,532.80

▲+22.76%from 30d ago

1Y Return

15.13%

Trailing 12 months

Net Asset Value

$187

▲+17.80%from 30d ago

Holders

36

▲+28.57%from 30d ago

Monthly Transfer Volume

$7.46

AstraZeneca PLC

Return Target

Not supplied yet.

Asset Class

Stocks

Exposure

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Liquidity

Redemptions: Instant

Asset Manager

Asset manager details have not been supplied yet.

Management Team

Management team details have not been supplied yet.

AstraZeneca PLC Performance

Loading performance history…

Fees

Subscription fee
0%
Redemption fee
0%

Subscriptions & Redemptions

Funding option
USDC
Eligible Investors
Non-U.S. Global Retail
KYC required
Yes

Subscriptions

Subscription frequency
Instant

Redemptions

Redemption frequency
Instant

Legal Structure & Regulation

Legal issuer
Dinari, Inc.
Tokenization Sponsorship
Third-Party
Issuer CIK
Legal structure
U.S. Corporation
Regulatory Framework

U.S. Securities Act Reg. S Exemption

SEC - U.S. Securities and Exchange Commission

Regulatory jurisdiction
United States of America
Inception date
11/13/2023

Service Providers

Traditional broker
Dinari Securities iconDinari Securities

AstraZeneca PLC Metrics

Token & Networks

Platform
Tokenization type
Transferability
Transferable within whitelist
Token supply
13.56
▲
Circulating supply
13.56
▲

Blockchain Networks

Network
Type
Tokenization
Type
Token Standard
Token Supply
Circulating Supply
Bridged Supply
Holders
Trailing 30D
Active Addresses
Monthly
Transfer Volume
Monthly
Transfer Count
Contract Address
Native
ERC-20
9.81
▲
Native
ERC-20
3.75
▲
Native
ERC-20
—
Native
ERC-20
—
Native
ERC-20
—
Native
ERC-20
—
Native
ERC-20
—
Native
ERC-20
—
Native
ERC-20
—

Holders

All networks · changes vs. 30 days ago

Holding addresses
36▲+0.29%
Active (30D)
3▲+0.50%

View detailed token
holder breakdowns

Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.

Holders Product Screenshot

Transactions

All networks · changes vs. 30 days ago

Transfers (30D)
3
Volume (30D)
$7.46